Tardive Dyskinesia Awareness
Eduardo Dunayevich, MD, Vice President, VMAT2 Franchise Leader, and Clinical Business Development Leader for Neurocrine Biosciences, Inc.
5240 articles
Eduardo Dunayevich, MD, Vice President, VMAT2 Franchise Leader, and Clinical Business Development Leader for Neurocrine Biosciences, Inc.
Returning guest, Beth Battaglino, RN-C, CEO of HealthyWomen discusses the new survey results and outlines how those results call for encouraging better ...
Joe Todisco, CEO of CorMedix, a biopharmaceutical company focused on developing and commercializing therapeutic products that prevent infection and othe...
Patricia Hunt, PhD, Regents Professor in the School of Molecular Biosciences at Washington State University discusses her recent award, as well as her r...
Peter Berglund, Chief Scientific Officer of HDT Bio, discusses the development of a next-generation RNA vaccine platform for infectious diseases and can...
Yael Shvetz, 54, shares her story of surviving a rare hemorrhagic stroke, or brain bleed, to inspire and educate other women like herself.
A bright, confident smile can light up a room, exuding warmth and approachability. Learn more on Health Professional Radio.
Allen Comer, Senior Director, Research at Stratatech Corporation, a Mallinckrodt company, discusses a recent advancement in burn care and why there shou...
Christopher Flowers, M.D., Department of Lymphoma - Myeloma, Division of Cancer Medicine and chair of Lymphoma & Myeloma at The University of Texas MD A...
Cynthia Silva, Vice President of Clinical Affairs at Outset Medical discusses a recent abstract that was presented at the National Kidney Foundation (NK...